相关实验视频
Updated: Sep 18, 2025

16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
25.0K
复苏的变化影响了严重受伤者炎症并发症的发展和严重程度
Karlijn J P van Wessem1, Kim E M Benders2, Luke P H Leenen2
1Department of Trauma Surgery, University Medical Center Utrecht, Suite G04.232, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands. kwessem@umcutrecht.nl.
概括
重生策略转向更少的晶体质和更多的新鲜冷血 (FFP),减少ARDS但增加血栓栓塞. FFP可以减轻炎症并发症,支持当前的创伤复苏方案.
科学领域:
- 创伤复苏策略 创伤复苏策略
- 关键护理医学 关键护理医学
- 败血症和器官衰竭研究研究
背景情况:
- 创伤复苏已经从积极的晶体转向平衡的血液产品,包括新鲜冷血 (FFP).
- FFP的使用旨在减少严重受伤患者的器官衰竭和死亡率.
- 有关FFP与增加感染和败血症风险的关联存在担忧.
研究的目的:
- 研究不断发展的复苏策略对严重受伤患者的炎症并发症和死亡率的影响.
- 分析结晶体和FFP管理与MODS,ARDS,感染和血栓栓塞等结果之间的关联.
- 评估FFP在调节创伤后炎症反应中的作用.
主要方法:
- 一个11年的回顾性队列研究,重伤患者 (>15年) 进入1级创伤中心ICU.
- 排除标准包括孤立的头部伤害,溺水,窒息,烧伤和早期死亡率 (<48小时).
- 收集的数据包括人口统计,复苏液量 (晶体,FPF),炎症并发症 (MODS,ARDS,感染,血栓塞栓症) 和死亡率.
主要成果:
- 在研究期间,晶体剂的服用量下降,而FFP的服用量在24小时内增加.
- 增加的FFP使用与急性呼吸困扰综合征 (ARDS) 的减少相关,但血栓栓塞事件的增加.
- 结晶体独立预测多器官功能障碍综合征 (MODS),感染和死亡率;FFP与MODS和血栓栓塞有关.
结论:
- 在创伤复苏中,转向减少晶体质和增加FFP的转变可能会减少ARDS,但会增加血栓栓塞并发症.
- 炎症并发症的低死亡率表明轻度严重程度,可能受到FFP的抗炎作用的影响.
- 需要进一步的研究来优化FFP剂量,以平衡凝血病,体积恢复和炎症反应管理,以减轻血栓栓塞的风险.
相关概念视频
Inflammatory Response
8.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
8.5K
Acute Respiratory Failure-V
215
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
215
Inflammatory Response I: Vascular and Cellular
12.6K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
12.6K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
5.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
5.7K
Inflammation
55.5K
Overview
55.5K
Cardiopulmonary Resuscitation IV: Pharmacological Management
84
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
84

